Turkish Version of The Lower Limb Assessment Score

Hypermobility, Joint Clinical Trial

Official title:

Turkish Version of The Lower Limb Assessment Score : Reliability and Validity

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05558202
• Other study ID #: LLAS Study
• Status: Completed
• Start date: September 30, 2022
• Est. completion date: December 30, 2022

Study information

• Verified date: August 2023
• Source: Kutahya Health Sciences University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Hypermobility is more than normal joint laxity, mobility, and range of motion. It is characterized by increased laxity and fragility of connective tissues. Symptoms from hypermobility can begin at any age and affect women more than men. People are at higher risk than other people. It is stated that hypermobility is an important factor in orthopedic injuries and diseases. Individuals with hypermobility have more frequent orthopedic complaints and the problems are usually idiopathic and chronic. Studies have reported that proprioception and musculoskeletal reflex function may be affected independently of symptoms in hypermobile individuals. Therefore, evaluating hypermobility is very important in preventing hypermobility-related problems and injuries and developing appropriate treatment methods. Although the Beighton score is the most commonly used scoring method to determine hypermobility, it may be insufficient to determine hypermobility of the lower extremities. The Lower Limb Assessment Score (LLAS) has been reported to be one of the most appropriate scoring methods for assessing lower extremity hypermobility in the literature. The aim of this study is to adapt LLAS to Turkish and measure its validity and reliability.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 90
• Est. completion date: December 30, 2022
• Est. primary completion date: October 30, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 35 Years

Eligibility

Inclusion Criteria:

• Healthy volunteers

• Aged between 18 to 35

Exclusion Criteria:

• Using assistive devices or orthoses for the upper extremity

• Surgery history of the upper extremity

• Pain located on the upper extremity in the last 6 months

• Previous trauma that might restrict normal range of motion.

• Having degenerative or inflamatuar disease

Related Conditions & MeSH terms

• Hypermobility, Joint
• Joint Instability

Intervention

Other:
• Turkish validity and reliability
Explanation of the Turkish version of the scale. Translating the Turkish version of the scale into English to ensure consistency with the original scale. First application of scales to participants by two examiners separately. Second application of the scales to the participants by one examiner. Statistical analysis and scaling

Locations

Country	Name	City	State
Turkey	Kutahya Health Science University	Kutahya

Sponsors (1)

Lead Sponsor	Collaborator
Kutahya Health Sciences University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The Lower Limb Assessment Score (LLAS)	The LLAS was designed to test the mobility of many joints of the lower limb in multiple planes of motion. These tests include passive physiological, passive accessory and active range of motion.; The LLAS is performed on both lower limbs, each providing a score to a maximum of 12.	10 minutes
Primary	The Beighton Score	The Beighton Score is a set of manoeuvres used as the standard method of assessment for Generalised Joint Hypermobility. The Beighton score arbitrarily investigates the presence of hyperlaxity (yes = 1, no = 0) at both wrists, the fifth metacarpo-phalangeal joints, elbows, knee joints, and the lumbosacral spine. The items are summed and yield a Beighton score ranging from 0 to 9 points.	5 minutes